Gastroenterology
Pancreatic Cysts
6
Pipeline Programs↗
2
Active Trials↗
6
Companies Involved↗
Pancreatic cysts is an early-stage landscape with 6 programs across 6 companies. The most active players are Astellas, Roche, Milestone Pharmaceuticals Inc.. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 21
Phase 31
Approved
No programs
Analysis
Trial Status
5
clinical trials
Terminated1 · 20%
Unknown status1 · 20%
Active, not recruiting1 · 20%
Completed1 · 20%
Recruiting1 · 20%
Clinical Trials
Trial Activity
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)